Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Audited Results for the year ended 31 December 2024
-
IDEX Biometrics ASA: Annual report 2024
-
Equasens: EXCLUSIVE NEGOTIATIONS INITIATED WITH A FRENCH SOFTWARE EDITOR
-
NB Private Equity Partners Announces Transaction in Own Shares
-
Quadient: 11% Increase in Software Sales to Mail Clients in 2024 Reflects Rising Demand for Smarter, Multichannel Communications
-
Q1 Trading Update
-
Q1 2025 financial statements
-
Press release - Q1 2025 Results
-
Notice to convene the Annual General Meeting of Shareholders of Aktsiaselts Tallinna Vesi
-
Annual Report 2024 published
-
Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation
-
Cabka Receives B Score in Second CDP Climate Assessment
-
Interim Report - January-March 2025
-
TCM Group A/S: Major shareholder announcement
-
Four new female directors will bring gender parity to the Lleida.net Board
-
DSV, 1155 - INTERIM FINANCIAL REPORT Q1 2025
-
DSV, 1154 - DSV COMPLETES THE ACQUSITION OF SCHENKER
-
Strong Q1 2025 financial results and integration gaining momentum
-
Technip Energies First Quarter 2025 Financial Results
-
Transaction in Own Shares
-
Port Access Approval Received as Last Key Item for FID at Minim Martap Bauxite Project
-
Resolutions of the General Ordinary Shareholders Meeting of INVL Baltic Real Estate
-
Shareholders of INVL Baltic Real Estate approved the proposals to adopt a new version of the Articles of Association, reduce the share capital, and distribute dividends for the year 2024
-
Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
-
Nicox Provides Full Year 2024 Financial Results
-
New share buyback programme
-
Ringkjøbing Landbobank’s quarterly report for the first quarter of 2025
-
Credit Agricole Sa: Results first quarter 2025 - INCREASED REVENUES, STRONG PROFITABILITY DESPITE EXCEPTIONAL HIGH TAX IMPACT
-
Idorsia announces financial results for the first quarter 2025 – QUVIVIQ taking off in Europe and TRYVIO REMS removal increases the value of this outstanding asset
-
Start of Day Message
-
Nexans - Q1 2025, promising start to the year
-
ArcelorMittal S.A.: ArcelorMittal reports first quarter 2025
-
Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
-
Ress Life Investments A/S to divest most of its current life insurance portfolio
-
Melexis Q1 2025 results – First quarter sales of 198.2 million EUR
-
dsm-firmenich Q1 2025 trading update
-
Ontex shows margin resilience in Q1, and confirms full year outlook
-
Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter
-
Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery
-
Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO
-
Hiab's interim report January–March 2025: Profitability improved driven by strong execution in all divisions
-
CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings
-
AS Ekspress Grupp: Consolidated unaudited interim report for Q1 of 2025
-
EfTEN Real Estate Fund AS unaudited results for 1st quarter 2025
-
Equinor to commence second tranche of the 2025 share buy-back programme
-
Equinor ASA: Key information relating to cash dividend for first quarter 2025
-
Equinor first quarter 2025 results
-
Societe Generale: First quarter 2025 earnings
-
Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia
-
Hepsor AS consolidated unaudited interim report for Q1 2025

